Publications

 

Glassman Testimony

Testimony on the US Response to the Ebola Epidemic in West Africa

4/8/16

On April 7, 2016, CGD’s vice president for programs and director of global health policy Amanda Glassman testified before the Senate Foreign Relations Subcommittee on Africa and Global Health Policy at a hearing examining progress made in addressing the West Africa Ebola epidemic and its secondary effects.

FDA’s Role in Improving the Development Pathway for Neglected Disease Therapies - Congressional Testimony

6/23/10

Visiting Fellow Tom Bollyky testified before the U.S. Senate Appropriations Subcommittee on Agriculture, Rural Development, the Food and Drug Administration, and Related Agencies on how the FDA can help develop programs for neglected diseases. Programs for neglected diseases, such as tuberculosis, malaria and other parasitic illnesses, lack a regulatory infrastructure to ensure programs work properly.